A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene
A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene
With the objective of identifying candidate tumor suppressor genes, we used fluorescence in situ hybridization to map leukemia-related deletions of the long arm of chromosome 6 (6q). Twenty of 24 deletions overlapped to define a 4.8-Mb region of minimal deletion between markers D6S1510 and D6S1692 within chromosome 6 band q16. Using reverse transcription-PCR, we found evidence of expression in hematopoietic cells for 3 of 15 genes in the region (GRIK2, C6orf111, and CCNC). Comparison between our own and published deletion data singled out GRIK2 as the gene most frequently affected by deletions of 6q in acute lymphocytic leukemia (ALL). Sequence analysis of GRIK2 in 14 ALL cases carrying heterozygous 6q deletions revealed a constitutional and paternally inherited C to G substitution in exon 6 encoding for an amino acid change in one patient. The substitution was absent among 232 normal alleles tested, leaving open the possibility that heterozygous carriers of such mutations may be susceptible to ALL. Although low in all normal hematopoietic tissues, quantitative reverse transcription-PCR showed higher baseline GRIK2 expression in thymus and T cells than other lineages. Among T-cell ALL patients, 6q deletion was associated with a statistically significant reduction in GRIK2 expression (P = 0.0001). By contrast, elevated GRIK2 expression was measured in the myelomonocytic line THP-1 and in one patient with common ALL. Finally, we detected significant levels of GRIK2 expression in prostate, kidney, trachea, and lung, raising the possibility that this gene may be protective against multiple tumor types.
4089-4098
Sinclair, Paul B.
6453ef9d-248b-415a-8172-d693185689c8
Sorour, Amani
ee01c857-e37b-4296-9ed9-d17af3c609ca
Martineau, Mary
6cc6f57f-7b57-4583-81eb-17dac737e35c
Harrison, Christine J.
52da7673-509c-4b88-b92e-0c021c9c7d3e
Mitchell, Wayne A.
048d7ddb-e7ea-4324-996e-4938d733defa
O’Neill, Elena
5e3e3c19-56f7-41e6-a01f-8aba913ec77d
Foroni, Letizia
eba61549-49cb-4d42-8be9-dd39167c5f1f
2004
Sinclair, Paul B.
6453ef9d-248b-415a-8172-d693185689c8
Sorour, Amani
ee01c857-e37b-4296-9ed9-d17af3c609ca
Martineau, Mary
6cc6f57f-7b57-4583-81eb-17dac737e35c
Harrison, Christine J.
52da7673-509c-4b88-b92e-0c021c9c7d3e
Mitchell, Wayne A.
048d7ddb-e7ea-4324-996e-4938d733defa
O’Neill, Elena
5e3e3c19-56f7-41e6-a01f-8aba913ec77d
Foroni, Letizia
eba61549-49cb-4d42-8be9-dd39167c5f1f
Sinclair, Paul B., Sorour, Amani, Martineau, Mary, Harrison, Christine J., Mitchell, Wayne A., O’Neill, Elena and Foroni, Letizia
(2004)
A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene.
Cancer Research, 64 (12), .
Abstract
With the objective of identifying candidate tumor suppressor genes, we used fluorescence in situ hybridization to map leukemia-related deletions of the long arm of chromosome 6 (6q). Twenty of 24 deletions overlapped to define a 4.8-Mb region of minimal deletion between markers D6S1510 and D6S1692 within chromosome 6 band q16. Using reverse transcription-PCR, we found evidence of expression in hematopoietic cells for 3 of 15 genes in the region (GRIK2, C6orf111, and CCNC). Comparison between our own and published deletion data singled out GRIK2 as the gene most frequently affected by deletions of 6q in acute lymphocytic leukemia (ALL). Sequence analysis of GRIK2 in 14 ALL cases carrying heterozygous 6q deletions revealed a constitutional and paternally inherited C to G substitution in exon 6 encoding for an amino acid change in one patient. The substitution was absent among 232 normal alleles tested, leaving open the possibility that heterozygous carriers of such mutations may be susceptible to ALL. Although low in all normal hematopoietic tissues, quantitative reverse transcription-PCR showed higher baseline GRIK2 expression in thymus and T cells than other lineages. Among T-cell ALL patients, 6q deletion was associated with a statistically significant reduction in GRIK2 expression (P = 0.0001). By contrast, elevated GRIK2 expression was measured in the myelomonocytic line THP-1 and in one patient with common ALL. Finally, we detected significant levels of GRIK2 expression in prostate, kidney, trachea, and lung, raising the possibility that this gene may be protective against multiple tumor types.
This record has no associated files available for download.
More information
Published date: 2004
Identifiers
Local EPrints ID: 26608
URI: http://eprints.soton.ac.uk/id/eprint/26608
ISSN: 0008-5472
PURE UUID: 6d3d64b2-81b9-4a08-b4cb-939082b86729
Catalogue record
Date deposited: 21 Apr 2006
Last modified: 22 Jul 2022 20:35
Export record
Contributors
Author:
Paul B. Sinclair
Author:
Amani Sorour
Author:
Mary Martineau
Author:
Christine J. Harrison
Author:
Wayne A. Mitchell
Author:
Elena O’Neill
Author:
Letizia Foroni
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics